FARO Academy

Liposome administration routes significantly influence drug delivery outcomes, affecting biodistribution, immune response, and therapeutic efficacy. Depending on the target tissue and desired effect, liposomes can be delivered via intravenous, intranasal, intradermal, intraperitoneal, or even intraventricular routes. Each method offers unique advantages—such as enhanced site-specific accumulation, prolonged circulation, or improved cellular uptake. Creative Biolabs supports a wide range of administration strategies tailored to research needs, including systemic, localized, and mucosal delivery. Selecting the optimal route ensures effective delivery of encapsulated agents like clodronate or RNA, enabling precise control over pharmacokinetics and therapeutic impact in both preclinical and translational applications.